Bexorg, Inc.

📍 New Haven, United States🗓 Founded 2021👥 38 employees💰 Last funded Sep 2025
Biotechnology Research🌐 bexorg.com
Website LinkedIn
Bexorg is a privately held techbio company with the first-ever full tech stack platform to support CNS drug discovery and development in the human brain in a way that has not been possible before.  Our proprietary whole-brain perfusion technology can be used to study brain connectivity, circuit function, and disease processes, with the aim to identify novel targets, biomarkers, and effectiveness of therapeutics for neurological disorders before going into the clinic. Our proprietary BrainEx platform generates high-fidelity human brain molecular datasets that drive our XO Digital application, a machine learning and AI-centered engine for drug discovery and development. In collaboration with the NIH, Bexorg’s founders have been at the forefront of bioethics in post-mortem human brain scientific research, and we have an independent board comprised of bioethics leaders to ensure our operations maintain the highest standards. Bexorg is strategically partnering with leading neuroscience companies to integrate its platform into CNS clinical development programs, as well as advancing in-house neurodegeneration assets.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Bexorg, Inc.?
Bexorg, Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did Bexorg, Inc. last raise funding?
The most recent investment in Bexorg, Inc. recorded on gritt.io was in September 2025.
When was Bexorg, Inc. founded?
Bexorg, Inc. was founded in 2021.
What industry is Bexorg, Inc. in?
Bexorg, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Bexorg, Inc. based?
Bexorg, Inc. is headquartered in New Haven, United States.